top of page
Browse by category
Search


Endevica Bio reports co-agonism of the melanocortin-3 and -4 receptors drives robust weight loss
Endevica Bio has announced that the co-agonism of the melanocortin-3 and melanocortin-4 receptors (MC3/4R) drives robust weight loss,...


Endevica Bio spins off new company Abisati to develop weight loss drug
Endevica Bio is to spin-off of a newly created company called Abisati to develop an oral weight loss treatment that has shown efficacy in...
Browse by tag






bottom of page

